A quick read of the article that was posted:
The system my wife works for is not sending tests out to a lab like the ones mentioned in the article. They want to know, they're paying for it, they get the results and can share them.The Centers for Medicare and Medicaid Service (CMS), which oversees the regulatory process for US labs, requires genome-sequencing tests to be federally approved before their results can be disclosed to doctors or patients. These are the tests that pick up on variants, but right now, there's little incentive for the labs to do the work to validate those tests.
Of course the article has a clickbait title designed to make everyone think they can't be told. In truth, it really doesn't matter which one you have, staff is treating your symptoms as best they can.
"Gunfighting is a thinking man's game. So we might want to bring thinking back into it."-MDFA
Beware of my temper, and the dog that I've found...
As far as I know, it's the same test for both viruses, which means that most people will never know for sure what virus they got. The lab down the hall from me is sequencing virus. I can't remember how many per week--maybe a hundred. I've seen some of their data, and I talk with that colleague pretty frequently. Delta is definitely real. We had a local variant pop up, which I was afraid was going to be a super delta. Fortunately it wasn't.
Sent from my moto e5 cruise using Tapatalk
I think that the currently available vaccines definitely help reduce community transmission. Last week my state was the world leader in new cases per capita and we have an abysmally low vaccination rate. Vermont, that has the highest vaccination rate, is not overrun with COVID patients. Getting a third immunization now will give me a big jump in antibody levels. A reasonable percentage of those antibodies will recognize the delta variant. As time passes and antibody levels drop, my susceptibility to Delta would increase again. However, by that point, community transmission will be much lower, so it won't be as much of danger. The molecular changes between the alpha and delta variants aren't nearly as significant and the potential changes in flu from year to year. The receptor binding domain of the spike protein of Delta differs from the Alpha strain at just three amino acids. In any case, the vaccine efficacy is a combination of the titer of the antibodies and how well they recognize the virus. I can game my titers right now with a third vaccination, but I can't do anything about how well the vaccine matches the virus in circulation. When SARS-CoV emerged in the early 2000s, most of the amino acid changes occurred in the first year after emergence. SARS-CoV-2 is obviously a much more successful virus, but I think the window will start to close soon on the potential for new variants. Worldwide, we've administered 5 billion doses of vaccine and had 215 million cases.
Got it. It's based on sampling, so not an actual count but not an assumption either.